Report Categories
View AllRecent Articles
View All
Lazard LAZ shares rally 35 despite 18 EPS miss revenue grows 2 YoY
OVID Ovid Therapeutics Inc far exceeds Q4 2025 EPS expectations shares rise nearly four percent
Why are smart money investors paying attention to StubHub Holdings STUB Trend Strengthens 20260508
Is trivago TRVG stock weakening trivago tops EPS views by 238 on travel demand
Equity Markets SP 500 Drops as Consumer Weighs
Tencent Holdings Limited TCEHY Signs GroupLevel Strategic Partnership With Towngas to Drive Energy Sector Digital Transformation
eToro ETOR Stock Is It Near Support eToro posts 111 EPS beat on robust trading growth
FTC Settlement With Media Matters Signals Regulatory Chill for Advertiser Oversight
Market Turmoil HDFC Sec Analyst Suggests Oracle Financial and Sun Pharma Amid Steep Selloff
Sunrun RUN Reports Strong Q1 2026 Revenue NA EPS Beats
Chime CHYM Q1 2026 Earnings Beat Revenue NA EPS 013
Should You Sell AGM Group AGMH After 1626 Drop 20260519
US Appeals Court Pauses Block on Trumps 10 Global Tariff
Michael Saylor Tokenization May Create a Free Market in Credit and Yield Challenging Traditional Banking
Oil Prices Post Weekly Decline as USIran Talks Show Potential Progress
The AI Economy Reshapes the Job Market BlueCollar Workers May Benefit as College Grad Hiring Slows
China Tightens Regulations on CrossBorder Stock Trading Key Points
Cigna Groups Dividend Growth History and Analyst Upgrade Highlight Potential for Income Investors
Hiding Wealth from Friends The Financial and Social Impact of Pretending to Be Strapped for Cash
MWA Q1 2026 Earnings EPS Beat Surprises Market Despite Revenue Uncertainty
LEVI Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution
MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress
FLWS Q1 2026 Earnings Deep EPS Miss Fails to Deter Investors as Stock Edges Higher
DTG Q1 2026 Earnings EPS Misses Estimates Underlying DTE Energy Performance Weighs on Debentures
Robin Energy Ltd RBNE Slips Toward Support as Selling Pressure Persists
Corbus Pharmaceuticals CRBP Under Pressure at 782 Key Support and Resistance in Focus
Pool Corporation POOL Faces Headwinds as Shares Slip Below 183
Osisko Development Corp ODV Drops 468 Key Support at 252 in Focus
Enanta Pharmaceuticals ENTA Dips 3 as Support at 1285 Comes into Focus
Aspire Biopharma Surges 18 as Bullish Momentum Builds Toward Key Resistance
USChina Trade Relations Three Signs from APEC Suggest Continued Rifts
JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI MD Discusses Growth Outlook